Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on the Outcomes of Patients With Metastatic Pancreatic Adenocarcinoma (MPA) During First-Line Treatment With FOLFIRINOX: A Single-Center Retrospective Analysis. | Cancer Control | 2023 | 36592369 | PubTator, text mining | PubMed |
| Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT). | Oncol Rep | 2023 | 36562382 | PubTator, text mining | PubMed |
| Design, synthesis, and evaluation of JTE-013 derivatives as novel potent S1PR2 antagonists for recovering the sensitivity of colorectal cancer to 5-fluorouracil. | Bioorg Chem | 2023 | 36527992 | PubTator, text mining | PubMed |
| Poor association between dihydropyrimidine dehydrogenase (DPYD) genotype and fluoropyrimidine-induced toxicity in an Asian population. | Cancer Med | 2023 | 36524458 | PubTator, text mining | PubMed |
| Aggressive migration in acidic pH of a glioblastoma cancer stem cell line in vitro is independent of ASIC and KCa3.1 ion channels, but involves phosphoinositide 3-kinase. | Pflugers Arch | 2023 | 36522586 | PubTator, text mining | PubMed |
| Epidemiology, presentation, and therapeutic approaches for hepatitis D infections. | Expert Rev Anti Infect Ther | 2023 | 36519386 | PubTator, text mining | PubMed |
| Molecular properties and regulation of NAD+ kinase (NADK). | Redox Biol | 2023 | 36512915 | PubTator, text mining | PubMed |
| Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation services. | Clin Transl Sci | 2023 | 36510710 | PubTator, text mining | PubMed |
| Genetic variants found in paediatric oncology patients with severe chemotherapy-induced toxicity: A case series. | J Oncol Pharm Pract | 2023 | 36464835 | PubTator, text mining | PubMed |
| Identification of DPYD variants and estimation of uracil and dihydrouracil in a healthy Indian population. | Per Med | 2023 | 36416570 | PubTator, text mining | PubMed |
| Fluoropyrimidine-associated toxicity and DPYD variants c.85T>C, c.496A>G, and c.1236G>A: impact of haplotype. | Cancer Chemother Pharmacol | 2023 | 36357798 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Characteristics and response to next-generation sequencing-guided therapy in locally advanced or metastatic esophageal cancer. | Int J Cancer | 2023 | 36214796 | PubTator, text mining | PubMed |
| Pharmacogenetic profiling via genome sequencing in children with medical complexity. | Pediatr Res | 2023 | 36167815 | PubTator, text mining | PubMed |
| The global disease burden attributable to a diet low in fibre in 204 countries and territories from 1990 to 2019. | Public Health Nutr | 2023 | 36138541 | PubTator, text mining | PubMed |
| DPYD and TYMS polymorphisms as predictors of 5 fluorouracil toxicity in colorectal cancer patients. | J Chemother | 2023 | 36137946 | PubTator, text mining | PubMed |
| Quantitative impact of pre-analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency. | Br J Clin Pharmacol | 2023 | 36104927 | PubTator, text mining | PubMed |
| Genomic medicine in Africa: a need for molecular genetics and pharmacogenomics experts. | Curr Med Res Opin | 2023 | 36094413 | PubTator, text mining | PubMed |
| Influence of the skeletal muscle index on pharmacokinetics and toxicity of fluorouracil. | Cancer Med | 2023 | 35941837 | PubTator, text mining | PubMed |
| Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients. | Cancer Med | 2023 | 35702826 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=33